Gene: STK32C
Official Full Name: serine/threonine kinase 32Cprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the serine/threonine protein kinase family. It is thought that this family member is functional in brain due to its high expression levels there. DNA methylation differences have been found in this gene in monozygotic twins that are discordant for adolescent depression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13680 | STK32C Knockout cell line (HeLa) | Human | STK32C | 1:3~1:6 | Negative | Online Inquiry |
KO13681 | STK32C Knockout cell line (HCT 116) | Human | STK32C | 1:2~1:4 | Negative | Online Inquiry |
KO13682 | STK32C Knockout cell line (HEK293) | Human | STK32C | 1:3~1:6 | Negative | Online Inquiry |
KO13683 | STK32C Knockout cell line (A549) | Human | STK32C | 1:3~1:4 | Negative | Online Inquiry |
STK32C Gene Knockout Cell Lines are engineered cellular models specifically designed to investigate the functional implications of the STK32C gene, which is implicated in various physiological processes and diseases. Generated through advanced CRISPR-Cas9 gene-editing technology, these cell lines are precisely crafted to exhibit a knockout of the STK32C gene, thereby enabling researchers to elucidate its role in cellular mechanisms, signal transduction pathways, and disease states.
The primary function of STK32C Gene Knockout Cell Lines is to provide a controlled platform for studying the loss-of-function effects of the STK32C gene. By observing cellular behaviors such as proliferation, apoptosis, and differentiation in the absence of STK32C expression, researchers can gain insight into its biological significance and potential as a therapeutic target. The mechanisms at play in these cell lines allow for detailed analysis of molecular interactions and phenotypic changes, making them invaluable tools in genetic, pharmacological, and pathological studies.
The scientific importance of these knockout cell lines cannot be overstated. They serve as critical assets for research institutions and biotechnology companies focused on the development of therapeutics for conditions associated with STK32C dysregulation, including cancer and metabolic disorders. In clinical settings, these cell lines can provide foundational knowledge that supports the advancement of personalized medicine approaches.
Compared to alternative models, such as wild-type cell lines or transiently transfected systems, STK32C Gene Knockout Cell Lines offer unparalleled specificity and stability, which are crucial for long-term experiments. Their robust phenotype allows for reproducible results, thereby enhancing the reliability of scientific findings and accelerating the translational process from bench to bedside.
For researchers, clinicians, and biotech professionals, the value of STK32C Gene Knockout Cell Lines lies in their ability to facilitate deeper biological insights, paving the way for novel discovery and innovation. Our company prides itself on its cutting-edge methodologies and commitment to providing high-quality biological products that empower the scientific community. With our robust expertise in genetic engineering, we ensure that each cell line is meticulously validated and ready for impactful research applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.